We use cookies. Find out more about it here. By continuing to browse this site you are agreeing to our use of cookies.
#alert
Back to search results

Manager, Clinical Operations

Alnylam Pharmaceuticals
United States, Massachusetts, Cambridge
675 West Kendall Street (Show on map)
Nov 12, 2024
Responsibilities:

Responsible for all aspects of clinical study planning and execution within pre-specified clinical development program, timelines and budget and includes, but is not limited to, preparation of study related materials, relationship management between study sites and vendors; in particular CRO(s), supervision of study related activities, identification of project risks and contingency planning.

Summary of Key Responsibilities:

* Lead and manage integrations of all project team activities; leveraging internal resources, expertise and knowledge, along with optimizing CRO resources, expertise and knowledge.

* Provide strategic input and execution of clinical trials from protocol design to the final clinical study report for specified studies.

* Effectively communicate and interact with Key Opinion Leaders.

* Manage all aspects of CRO/vendor identification, request for proposal submission, CRO selection, and the day to day operational management activities of CROs, with the ability to leverage resources, expertise, and knowledge within the CRO/vendor.

* Manage strategic study operations including: study sites and tracking systems for regulatory submissions, CRO monitor visit reports and site correspondence, drug supply and use, enrollment of subjects, regulatory document flow, study timelines, all budgetary and financial information, Pharmacovigilence/Serious Adverse Events, performance metrics, data flow, etc.

* Participate in Case Report Form design, user acceptance testing in partnership with data management

* Generate country specific Informed Consent Form development.

* Lead the development of contingency/risk management plans for projects and assist Director/Senior Director of Clinical Operations in the preparation and execution of sound development strategies.

* Budgets, timelines, and forecasts preparation for clinical studies.

* Interface with Finance, Program Management, Accounting, Supply Operations, Quality Assurance, Medical Affairs; which may include acting as a liaison between groups.

* Provide a variance analysis of budget to actual and notifies finance of projected cost over/under expenditure.

* Ability to travel (no more than annual average of 20%).

Requirements

* Bachelor's Degree is required. An advance degree in scientific discipline, business/finance courses is preferred.

* 6+ years of experience gained with a CRO or Pharmaceutical Company working on Phase I - IV multinational clinical studies.

* 3+ years clinical project management experience with clinical studies.

* Strong regulatory knowledge, including Good Clinical Practices (GCPs)

* Exceptional organizational skills and ability to deal with competing priorities, also strong reasoning and problem solving ability.

* Excellent communication skills (written and verbal), along with leadership skills.

* Solid presentation skills

* Knowledge of global clinical trial management in fast paced CRO outsourced environment. Ability to assemble a plan yet execute on the details.

* Apply project management best practices to programs. Experience in novel clinical drug development.

* Protocol, ICF, CRF, CSR design and review.

* Extremely strong organizational skills and ability to deal with competing priorities.

* Proficient with MS Office Suite (Excel, Word and PowerPoint) and MS Project.

About Alnylam:Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture:Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.

>
Applied = 0

(web-69c66cf95d-nlr4c)